Pyridam Farma Tbk PT banner

Pyridam Farma Tbk PT
IDX:PYFA

Watchlist Manager
Pyridam Farma Tbk PT Logo
Pyridam Farma Tbk PT
IDX:PYFA
Watchlist
Price: 330 IDR 6.45% Market Closed
Market Cap: Rp3.7T

Pyridam Farma Tbk PT
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Pyridam Farma Tbk PT
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Pyridam Farma Tbk PT
IDX:PYFA
Operating Income
-Rp144.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Operating Income
Rp1.7T
CAGR 3-Years
18%
CAGR 5-Years
13%
CAGR 10-Years
10%
Kalbe Farma Tbk PT
IDX:KLBF
Operating Income
Rp4.3T
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
4%
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Operating Income
Rp228.4B
CAGR 3-Years
50%
CAGR 5-Years
-1%
CAGR 10-Years
6%
Soho Global Health Tbk PT
IDX:SOHO
Operating Income
Rp567.7B
CAGR 3-Years
-5%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
Operating Income
-Rp530.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pyridam Farma Tbk PT
Glance View

Market Cap
3.7T IDR
Industry
Pharmaceuticals

PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.

PYFA Intrinsic Value
HIDDEN
Show

See Also

What is Pyridam Farma Tbk PT's Operating Income?
Operating Income
-144.8B IDR

Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's Operating Income amounts to -144.8B IDR.

What is Pyridam Farma Tbk PT's Operating Income growth rate?
Operating Income CAGR 1Y
-13%

Over the last year, the Operating Income growth was -13%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett